Clinical Trial Update: IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intermittent preventive therapy with sulfadoxine/pyrimethamine and chlorproguanil/dapsone in children aged 6-59 months with malaria; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Fansidar (sulfadoxine-pyrimethamine)
• Lapdap (chlorproguanil-dapsone)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 3 | Status: TERMINATED